ACCESSION: MSBNK-SMB_Measured-HSA001P0141007
RECORD_TITLE: Annotated; Metenamine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 14
COMMENT: RAW_SPEC {'BLK01_56': {'bp': 997338.0, 'sum': 2460227.0}, '14_posi_59': {'bp': 554288.0, 'sum': 1486993.0}, '1_posi_60': {'bp': 555692.0, 'sum': 1528558.0}, '12_posi_59': {'bp': 579896.0, 'sum': 1469320.0}, '2_posi_62': {'bp': 530656.0, 'sum': 1434001.0}, '9_posi_58': {'bp': 538463.0, 'sum': 1467138.0}, '16_posi_60': {'bp': 613462.0, 'sum': 1561344.0}, '4_posi_61': {'bp': 572033.0, 'sum': 1519427.0}, '8_posi_62': {'bp': 575011.0, 'sum': 1544408.0}, '10_posi_61': {'bp': 599308.0, 'sum': 1589751.0}, '19_posi_60': {'bp': 615936.0, 'sum': 1439102.0}, '5_posi_60': {'bp': 562216.0, 'sum': 1442822.0}, '6_posi_61': {'bp': 551529.0, 'sum': 1504828.0}, '17_posi_57': {'bp': 560999.0, 'sum': 1452052.0}}
COMMENT: RETENTION_TIME_STDEV 0.003
COMMENT: PRECURSOR_M/Z_RAW 141.113128
COMMENT: PRECURSOR_M/Z_STDEV 0.000042
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.014; C6H12N4; [M+H]+; delta(ppm) -0.014275
COMMENT: PROPOSED_MF MS-FINDER 3.577; C6H12N4; [M+H]+; delta(ppm) -0.020156
COMMENT: PROPOSED_MF SIRIUS5_Sirius 6.935; C6H12N4; [M+H]+; delta(ppm) -0.020156
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H12N4; [M+H]+; delta(ppm) -0.020156
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.368; C6H12N4; [M+H]+; delta(ppm) -0.020156
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.032; C8H14NO; [M+H]+; delta(ppm) -9.534845
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H12N4; [M+H]+; delta(ppm) -0.020156
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 3.000; VKYKSIONXSXAKP-UHFFFAOYSA-N; C6H12N4; Spectral Match to Methenamine from NIST14
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.500; VKYKSIONXSXAKP-UHFFFAOYSA-N; [M+H]+; C1N2CN3CN1CN(C2)C3
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.440; OKIYPFZZDQLNMP-UHFFFAOYSA-N; [M+H]+; CCCCCC1=NNN=N1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.780; VKYKSIONXSXAKP-UHFFFAOYSA-N; [M+H]+; Metenamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.416; OKIYPFZZDQLNMP-UHFFFAOYSA-N; [M+H]+; 5-pentyl-2H-tetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VKYKSIONXSXAKP-UHFFFAOYSA-N; [M+H]+; Metenamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.849; OKIYPFZZDQLNMP-UHFFFAOYSA-N; [M+H]+; 5-pentyl-2H-tetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.709; VKYKSIONXSXAKP-UHFFFAOYSA-N; [M+H]+; 1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; SGBUUHYQJQZIEF-UHFFFAOYSA-N; [M+H]+; 3-(5-methyl-2H-triazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; FXQOTTKAHLPLGZ-UHFFFAOYSA-N; [M+H]+; 4-(triazol-1-yl)butan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; FXVXCWWBFBEURF-UHFFFAOYSA-N; [M+H]+; 3-(5-methyl-1H-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; JGGUUJRQUZZUIB-UHFFFAOYSA-N; [M+H]+; 2-(4-methyl-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; HKIVZMPMDHNWNR-UHFFFAOYSA-N; [M+H]+; 3-(4-methyl-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; WMLLVXMZSGSSEU-UHFFFAOYSA-N; [M+H]+; 3-(1-methyl-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; BUEANCSGTDXMMH-UHFFFAOYSA-N; [M+H]+; 3-(2-methyltriazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.090; KYIVZQNAWBHHAT-UHFFFAOYSA-N; [M+H]+; 2-(3-ethyl-1H-1,2,4-triazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.089; MLGQMJALMNGPSR-UHFFFAOYSA-N; [M+H]+; (1-propan-2-yltriazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.089; LUXLFSWSHAECCA-UHFFFAOYSA-N; [M+H]+; (1-propyltriazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.089; ZFOZOCLSYJLZPG-UHFFFAOYSA-N; [M+H]+; (1-propan-2-yl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; UXVISKUHAHDCFI-UHFFFAOYSA-N; [M+H]+; 2-(1-ethyltriazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; OWZRZTYYKXCIAI-UHFFFAOYSA-N; [M+H]+; (4-propan-2-yl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.085; DWLZOAQNIPAAFO-UHFFFAOYSA-N; [M+H]+; 2-(4-ethyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.085; TYWRRCQYQXNVEK-UHFFFAOYSA-N; [M+H]+; 2-(4,5-dimethyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.082; OIVJDIWINLEWFU-UHFFFAOYSA-N; [M+H]+; 2-(3,5-dimethyl-1,2,4-triazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.081; HIWAIHBATLLXPU-UHFFFAOYSA-N; [M+H]+; 1-(1-methylpyrazol-4-yl)ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.081; CUTNSFKUMKABGS-UHFFFAOYSA-N; [M+H]+; N'-(2-methylpyrazol-3-yl)ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.066; VCTVUJOTOJYMIS-UHFFFAOYSA-N; [M+H]+; 2-methyl-5-propan-2-yl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.055; FRHFXFXZSQDYBC-UHFFFAOYSA-N; [M+H]+; (3-propan-2-yl-1H-1,2,4-triazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.944; FBILVWGTLWCYPU-UHFFFAOYSA-N; [M+H]+; 3-(azidomethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.943; IGHVGDCSIUTUFP-UHFFFAOYSA-N; [M+H]+; 4-(azidomethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.921; UVRLGILFHWSWKE-UHFFFAOYSA-N; [M+H]+; 5-methyl-1-propan-2-yl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.920; KEMNTRIYSIFNIW-UHFFFAOYSA-N; [M+H]+; (1-propan-2-ylpyrazol-3-yl)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.919; QURWPRWUDYEQNR-NTSWFWBYSA-N; [M+H]+; (1S,2R)-2-azidocyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.907; BGISKSHLHYGZFQ-UHFFFAOYSA-N; [M+H]+; 1-tert-butyl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.882; PZSRJLZFQGEFSY-RXMQYKEDSA-N; [M+H]+; (2R)-1-(1-methyltriazol-4-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.882; PXEAJKYSDKTUPF-RXMQYKEDSA-N; [M+H]+; (1R)-1-(3-methyltriazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.871; UNPBPOSGHGAKDM-UHFFFAOYSA-N; [M+H]+; 5-(2-methylpropyl)-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.865; ODGGHRYHUQOMIE-UHFFFAOYSA-N; [M+H]+; 4-(1,2,4-triazol-1-yl)butan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.865; KWCLNZQGWCJRBO-RXMQYKEDSA-N; [M+H]+; (1R)-1-(5-methyl-1H-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.865; LZTMJFUDZMELMK-UHFFFAOYSA-N; [M+H]+; 2-(5-methyl-1H-1,2,4-triazol-3-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.850; YYLBLMYFEQNWIL-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-1-yl)butan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.849; LNIXWHZGFOEORC-UHFFFAOYSA-N; [M+H]+; 2-methyl-1-(2H-triazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.841; JYXQLWGUUVLZPQ-UHFFFAOYSA-N; [M+H]+; 1-(5-ethyl-1H-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.784; MHDCDPXQCUJWCH-UHFFFAOYSA-N; [M+H]+; 2-butyl-1-cyanoguanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.781; BLFOJPQSVBUXAO-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-2-(1,2,4-triazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.742; OUEULNVXHMKTKS-UHFFFAOYSA-N; [M+H]+; 5-methyl-1-(2-methylpropyl)tetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.713; FGCGZUFQSOYAJG-UHFFFAOYSA-N; [M+H]+; 5-(2-methylbutan-2-yl)-2H-tetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -28.939; VKYKSIONXSXAKP; [M+H]+; Ammoform
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -182.681; BLFOJPQSVBUXAO; [M+H]+; 1-(2-Dimethylaminoethyl)-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.804; MHDCDPXQCUJWCH; [M+H]+; 1-Butyl-3-cyanoguanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -221.149; LOLVREZTZUWBEQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.552; NMHCNWRIEUCNEX; [M+H]+; ACMC-20lgjx
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -236.391; OUEULNVXHMKTKS; [M+H]+; 1-Isobutyl-5-methyl-1H-tetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -277.483; FGCGZUFQSOYAJG; [M+H]+; 5-(1,1-Dimethylpropyl)-5H-tetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.680; VKYKSIONXSXAKP; [M+H]+; Ammoform
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -72.507; VKYKSIONXSXAKP; [M+H]+; 1,3,5,7-tetraazatricyclo[3.3.1.1³,⁷]decane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -142.376; MHDCDPXQCUJWCH; [M+H]+; Guanidine, 1-butyl-3-cyano-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -200.367; UVRLGILFHWSWKE; [M+H]+; 1-Isopropyl-5-methyl-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -201.760; FRHFXFXZSQDYBC; [M+H]+; [5-(Propan-2-YL)-4H-1,2,4-triazol-3-YL]methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -202.885; BLFOJPQSVBUXAO; [M+H]+; 1H-1,2,4-Triazole, 1-(2-dimethylaminoethyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -211.580; BGISKSHLHYGZFQ; [M+H]+; 1-(tert-Butyl)-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -217.574; OUEULNVXHMKTKS; [M+H]+; 1-Isobutyl-5-methyl-1H-tetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -232.346; NMHCNWRIEUCNEX; [M+H]+; 2-Amino-5-methylhistamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -236.532; LOLVREZTZUWBEQ; [M+H]+; ethyl[(1-methyl-1H-1,2,3-triazol-4-yl)methyl]amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -259.125; FGCGZUFQSOYAJG; [M+H]+; 5-(1,1-Dimethylpropyl)-5H-tetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.402; VKYKSIONXSXAKP; [M+H]+; 1,3,5,7-tetraazatricyclo[3.3.1.1³,⁷]decane
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Metenamine, VKYKSIONXSXAKP-UHFFFAOYSA-N; Matching to 3 measured spectra (Dot product > 0.7); Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0029598;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C6H12N4
CH$EXACT_MASS: 140.106196
CH$SMILES: C1N2CN3CN1CN(C2)C3
CH$IUPAC: InChI=1S/C6H12N4/c1-7-2-9-4-8(1)5-10(3-7)6-9/h1-6H2
CH$LINK: CHEBI CHEBI:6824
CH$LINK: HMDB HMDB0029598
CH$NAME: Metenamine
CH$NAME: Metenamine
CH$NAME: 1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane
CH$LINK: INCHIKEY VKYKSIONXSXAKP-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:4101
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 0.126
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 141.113470
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0006-2900000000-4c5a8fa5f43203ada060
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  58.0650447 17.1540 58.065681 1.1711 3.49 0.7418 13 f{C3H8N1}/-1.39ppm,p-C3H5N3
  69.0447323 35.7760 69.045358 0.8835 5.64 0.0989 14 f{C3H5N2}/0.11ppm,p-C3H8N2
  70.0479311 23.1284 70.048551 1.4704 3.92 0.2044 14 ?
  70.0650412 21.5444 70.065661 1.9696 4.11 0.0813 14 f{C4H8N1}/-1.21ppm,p-C2H5N3
  71.0603939 62.9424 71.061007 0.5207 8.21 0.2308 14 f{C3H7N2}/0.27ppm,p-C3H6N2
  72.0443699 28.2241 72.044976 1.6518 4.43 0.1516 14 ?
  73.0475471 16.4724 73.048146 0.9446 2.48 0.4242 14 ?
  73.0758532 7.6116 73.076452 2.0116 1.76 -0.4231 13 f{C3H9N2}/-2.35ppm,p-C3H4N2
  85.0760358 124.0460 85.076515 0.3644 10.89 0.3670 14 f{C4H9N2}/0.13ppm,p-C2H4N2
  95.0602701 19.6534 95.060630 1.5674 22.75 -0.3626 14 f{C5H7N2}/-1.10ppm,p-C1H6N2
  97.0759186 9.6176 97.076264 1.8439 3.36 -0.2088 14 f{C5H9N2}/-1.09ppm,p-C1H4N2
  98.0713091 99.0318 98.071646 0.4385 7.73 0.4813 14 f{C4H8N3}/0.36ppm,p-C2H5N1
  100.0755118 10.6851 100.075833 1.2790 3.04 0.0330 14 ?
  107.0601041 16.0690 107.060361 1.3637 4.17 -0.0934 13 f{C6H7N2}/-2.53ppm,p-H6N2
  111.0914444 12.4337 111.091660 1.5123 3.79 -0.0330 14 f{C6H11N2}/-2.07ppm,p-H2N2
  112.0869718 317.9964 112.087176 0.1695 9.26 0.8022 14 f{C5H10N3}/0.43ppm,p-C1H3N1
  113.0708021 20.5340 113.070996 1.9899 4.37 0.1077 14 ?
  113.0821657 24.4218 113.082359 2.2550 2.62 0.3791 13 f{C4H9N4}/-0.06ppm,p-C2H4
  114.0660010 8.5582 114.066183 2.5862 2.56 0.3636 12 ?
  124.0869556 169.6775 124.087011 0.3788 52.10 -0.6044 14 f{C6H10N3}/0.26ppm,p-H3N1
  141.0662821 193.1033 141.066186 0.5529 25.63 0.2791 14 ?
  141.0860585 105.9190 141.085962 0.8576 9.41 0.4374 14 ?
  141.1022157 143.0688 141.102119 0.9851 20.08 -0.2000 14 ?
  141.1131728 999.0000 141.113076 0.4323 0.00 1.0000 14 f{C6H13N4}/-2.13ppm,p
PK$NUM_PEAK: 24
PK$PEAK: m/z int. rel.int.
  58.065045 17.15 17
  69.044732 35.78 35
  70.047931 23.13 23
  70.065041 21.54 21
  71.060394 62.94 62
  72.044370 28.22 28
  73.047547 16.47 16
  73.075853 7.61 7
  85.076036 124.05 124
  95.060270 19.65 19
  97.075919 9.62 9
  98.071309 99.03 99
  100.075512 10.69 10
  107.060104 16.07 16
  111.091444 12.43 12
  112.086972 318.00 317
  113.070802 20.53 20
  113.082166 24.42 24
  114.066001 8.56 8
  124.086956 169.68 169
  141.066282 193.10 193
  141.086058 105.92 105
  141.102216 143.07 143
  141.113173 999.00 999
//
